Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lloyd

Showing results (161-170 of 228) with videos related to

Pageof 23
Sort By:
Pharmacoeconomics|February 5, 2019
Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in SwedenSantiago Zuluaga-Sanchez, Megan Teynor, Christopher Knight, et al.
Clinical Pharmacokinetics|September 16, 2022
Correction to: Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK ModellingMaiara Camotti Montanha, Francesc Fabrega, Alice Howarth, et al.
The Patient|October 15, 2011
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluationsAndrew Lloyd, Paul Hodgkins, Rahul Sasane, et al.
International Journal of Cardiology|October 30, 2012
Reliability revisited: autonomic responses in the context of everyday well-beingVishal Patel, Sabine Giesebrecht, Alexander R Burton, et al.
Clinical Pharmacokinetics|October 12, 2021
Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK ModellingMaiara Camotti Montanha, Francesc Fabrega, Alice Howarth, et al.
Frontiers in Pharmacology|February 14, 2022
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver DiseaseMaiara Camotti Montanha, Nicolas Cottura, Michael Booth, et al.
Journal of Health Economics and Outcomes Research|February 24, 2025
A Vignette Study to Derive Health-Related Quality-of-Life Weights for Individuals with Steroid Refractory Chronic Graft-versus-Host Disease Receiving Third-Line Therapy in the United KingdomEmma Williams, Luke Skinner, Richard Hudson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceJohn F P Bridges, A Brett Hauber, Deborah Marshall, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2006
Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samplesWayne B Dyer, Sarah L Pett, John S Sullivan, et al.
Gut|March 18, 2009
The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infectionClovis Palmer, Theresa Corpuz, Marianne Guirguis, et al.
Pageof 23

Showing results (161-170 of 228) with videos related to

Sort By:
Pageof 23
Pharmacoeconomics|February 5, 2019
Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in SwedenSantiago Zuluaga-Sanchez, Megan Teynor, Christopher Knight, et al.
Clinical Pharmacokinetics|September 16, 2022
Correction to: Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK ModellingMaiara Camotti Montanha, Francesc Fabrega, Alice Howarth, et al.
The Patient|October 15, 2011
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluationsAndrew Lloyd, Paul Hodgkins, Rahul Sasane, et al.
International Journal of Cardiology|October 30, 2012
Reliability revisited: autonomic responses in the context of everyday well-beingVishal Patel, Sabine Giesebrecht, Alexander R Burton, et al.
Clinical Pharmacokinetics|October 12, 2021
Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK ModellingMaiara Camotti Montanha, Francesc Fabrega, Alice Howarth, et al.
Frontiers in Pharmacology|February 14, 2022
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver DiseaseMaiara Camotti Montanha, Nicolas Cottura, Michael Booth, et al.
Journal of Health Economics and Outcomes Research|February 24, 2025
A Vignette Study to Derive Health-Related Quality-of-Life Weights for Individuals with Steroid Refractory Chronic Graft-versus-Host Disease Receiving Third-Line Therapy in the United KingdomEmma Williams, Luke Skinner, Richard Hudson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceJohn F P Bridges, A Brett Hauber, Deborah Marshall, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2006
Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samplesWayne B Dyer, Sarah L Pett, John S Sullivan, et al.
Gut|March 18, 2009
The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infectionClovis Palmer, Theresa Corpuz, Marianne Guirguis, et al.
Pageof 23